New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, said Medtronic’s CEO Geoff Martha at the recent J.P. Morgan
Vertex has presented new data on its clinical trial VX-880, hailed as a potentially revolutionary treatment for people with Type 1 diabetes. VX-880 is a
The University of Liverpool’s AI diagnostic technology spin-out, AI-Sight, has successfully concluded its seven-figure equity funding round from experienced healthcare industry figures and investors. The
This issue feels a little heavy, as a few topics are tough ones, about people feeling stigma, shame or simply experiencing a build-up of comments
New research has showed that the majority of patients achieving high rates of glucose control and weight loss in the first year of tirzepatide treatment
Sheffield Teaching Hospitals NHS Foundation Trust has launched a trial utilising smart technologies with the aim of reversing the risk of nerve damage in people
The NHS has produced an online tool that can help people decide between the different technology available to manage Type 1 diabetes. The comprehensive sheet
Breakthrough T1D is holding a Virtual Discovery Event in March on the top if of research. Taking place on Tuesday 4 March from 7-8.45pm it
People living with obesity are invited to come together with academics, clinicians, public health practitioners, as well as national and local policy makers at a
Anne L. Peters, MD has published some thoughts on using sodium-glucose cotransporter 2 (SGLT2) inhibitors in people with Type 1 diabetes. Early on, she noted
